RÉSUMÉ
In a 24 -year -old woman, a tumor was detected unexpectedly under the left flank of the body in an examination. Ultrasound found the tumor on the retro-peritoneum, UIV showed the less absorption of medicament in the right side of the kidney, which was pushed up and the normal function of left side of the kidney. In operation, a retro-peritoneal tumor was exposed at the right side with a bulk of surrounded large vessels. Pathologic anatomy showed that it was a malign hemangiopericytoma. One year after the operation, patient survived normally.
Sujet(s)
Hémangiopéricytome , Thérapeutique , Diagnostic , PéritoineRÉSUMÉ
Hemangiopericytoma is a relatively uncommon vascular tumor. It was first described by Stout and Murray in 1942. Here, we report a case of a primary prostatic hemangiopericytoma, which has been reported approximately <10 cases. This may be the first case of a prostatic hemangiopericytoma in Korea. A 35-year-old male patient presented with an episode of dysuria and perineal discomfort over the past 3 months. The radiological and histological features indicated a malignant hemangiopericytoma. Systemic chemotherapy was selected as the primary treatment. After 5 cycles of chemotherapy, the size of masses of the prostate and lung decreased. Four months after then, the patient died from hemoptysis.
Sujet(s)
Adulte , Humains , Mâle , Traitement médicamenteux , Dysurie , Hémangiopéricytome , Hémoptysie , Corée , Poumon , ProstateRÉSUMÉ
Hemangiopericytoma is a relatively uncommon vascular tumor. It was first described by Stout and Murray in 1942. Here, we report a case of a primary prostatic hemangiopericytoma, which has been reported approximately <10 cases. This may be the first case of a prostatic hemangiopericytoma in Korea. A 35-year-old male patient presented with an episode of dysuria and perineal discomfort over the past 3 months. The radiological and histological features indicated a malignant hemangiopericytoma. Systemic chemotherapy was selected as the primary treatment. After 5 cycles of chemotherapy, the size of masses of the prostate and lung decreased. Four months after then, the patient died from hemoptysis.